BLS
BLS PHARMACEUTICALS ORDINARYBLS Pharmaceuticals Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czech Republic, and Japan. The company offers medical cannabis, MDMA, psilocybin, prescription medicines, probiotics, NADs, and consumer health products under the Dr Watson and PCC brands. It also provides pharmaceutical manufacturing, wholesale, distribution, import, export, and contract drug manufacturing services for investigational and psychotropic medicines. The company caters to licensed clinics, pharmacies, wholesale distributors, cultivators, active pharmaceutical ingredient manufacturers, and pharmaceutical brand sponsors. The company was formerly known as Bioxyne Limited and changed its name to BLS Pharmaceuticals Limited in June 2026. BLS Pharmaceuticals Limited was incorporated in 1998 and is headquartered in Sydney, Australia.
BLS
BLS
BLS PHARMACEUTICALS ORDINARY
BLS Pharmaceuticals Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czech Republic, and Japan. The company offers medical cannabis, MDMA, psilocybin, prescription medicines, probiotics, NADs, and consumer health products under the Dr Watson and PCC brands.
Fundamentals
Historical Data7 days
| Date | Short % | Gross Short |
|---|---|---|
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 0.02% | — |
| 10 July | 0.02% | — |
| 9 July | 0.02% | — |
| 8 July | 0.02% | — |
| 7 July | 0.02% | — |
Bls Pharmaceuticals (BLS) Short Interest Summary
Bls Pharmaceuticals (BLS) currently has 0.02% of its shares sold short (50 thousand shares, worth approximately $47K), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes BLS the #571 most shorted stock on the ASX most shorted list. BLS is part of the Consumer Staples sector on the ASX.
Recent BLS Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 0.02% | 0.1M | $0.97 |
| 10 July 2026 | 0.02% | 0.1M | $0.90 |
| 9 July 2026 | 0.02% | 0.1M | $0.81 |
| 8 July 2026 | 0.02% | 0.1M | $0.81 |
| 7 July 2026 | 0.02% | 0.1M | $0.93 |
BLS Short Selling — Frequently Asked Questions
What is Bls Pharmaceuticals (BLS)'s current short interest?
Bls Pharmaceuticals (BLS) currently has a short interest of 0.02% of total shares outstanding. This means 0.02% of BLS's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is BLS heavily shorted on the ASX?
BLS has a relatively low short interest of 0.02%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for BLS investors?
Short interest in BLS shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.02%, BLS's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this BLS short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for BLS.